Australia's most trusted
source of pharma news
Friday, 10 July 2026
Friday, 10 July 2026
Subscribe
Login
Novartis settles legal case with Zeller
Novartis has settled a legal stoush with its former ANZ Country President Matt Zeller who left the company last September to take up the CEO role at Arrotex.
Which company has the best MSLs?
Although the race was neck-and-neck, one company came out on top, according to a survey of oncologists in the US
TODAY
Next up: a weight loss implant
First there were injections, then pills. Now Novo Nordisk is taking convenience for patients to the next level with weight loss implants
TODAY
Star shines light on RSV risk
GSK teams up with well-known actress to raise awareness about the dangers of RSV for older Australians
TODAY
Butler fires a delisting warning shot
Minister sends a message loud and clear to both PBAC and two pharmas as public pressure mounts over feared PBS delisting
9 July
Another GM gone, successor named
Yet another company has announced the departure of its General Manager, with a replacement already named
8 July
Extra leave coming to pharma?
Gen Z already makes up a third of the workforce and they already hold a crucial bargaining chip in workplace negotiations
8 July
Latest Jobs
Distribution Clerk - WarehousingCommercial SpecialistLogistics PlannerLogistics and Customer Service SpecialistTrade Marketing ManagerCustomer Service RepresentativeClinical Trial InvestigatorSenior Medical Receptionist - 2IC38 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (24)
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Perth
- Inside Sales Specialist - Melbourne
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
Access & Reimbursement (1)
Clinical & Medical, R&D (6)
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
- Clinical Trial Investigator - Melbourne
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
Regulatory, Pharmacovigilance & QA (4)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
Other (11)
- Distribution Clerk - Warehousing - Jacana
- Commercial Specialist - Brisbane
- Logistics Planner - North Ryde
- Warehouse Assistant - Eight Mile Plains
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
Another drug leaving Australia
'Commercial changes' and 'commercial viability' given as the reasons behind this company's decision to cease supply
8 July
GM tells why it was time to resign
In a heartfelt goodbye, this country leader has spoken about the personal "sliding door moment" that led to her decision to leave
9 July
Lilly, patient group invest $680K
Eli Lilly Australia and a well-known patient group have joined forces to improve digital health solutions for complex care
9 July
'Yes' with a price cut, patient cap
MSAC has supported public funding for a blood drug but with heavy conditions, just days after knocking back another new medicine
9 July
Ex-Pfizer HQ verging on collapse
Support columns inside the company's former global headquarters in New York City have buckled, sparking immediate evacuations
9 July
Red carpet win for cheeky campaign
A humorous ad for a serious disease has seen this company take home a prestigious award considered an 'Oscar' in industry
8 July
2 complete responses in 4 weeks
More astonishing success as trial logs two complete responses in a month for blood cancer patients that had previously failed therapy
8 July
Company lands its biggest buy ever
Shells out $14B to expand its therapeutic footprint and it's snagged a drug that's already exceeding sales forecasts
8 July
J&J to pull drug worldwide
The US pharma giant has confirmed the long-standing treatment will be removed from the Australian market this year
7 July
Revenue soars 25% after broad listing
Patients and prescribers have wasted no time embracing the broad listing of immunotherapies, with use jumping straight away
7 July
Novartis buys Aussie-backed firm
Pays more than $2 billion for an ADC biotech backed by Australian venture capital firm Brandon Capital
7 July
New FY brings fresh career start
The new financial year kicks off with a round of job moves including promotions, departures and retirements
7 July
Drug dropped from PBAC meeting
A new treatment will now be considered at a future PBAC meeting, with a pending TGA decision likely the reason
7 July
Who's been named GM... again?
Two years after stepping away from a GM role this executive is back at the top working for a new company
6 July
Blockbusters stuck in PBS limbo
Seven drugs recommended in March have been marked 'inactive' including two of the world's up-and-coming top-sellers
6 July